Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00963250
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
009![]() | (4S)-1,4-dibenzyl-N-[(1S,2R)-1- benzyl-3-{[3-(dimethylamino)benzyl]amino}- 2-hydroxypropyl]-2-oxoimidazolidine- 4-carboxamide | A,B,C | 3CKR | 0.74 | ![]() |
MNI![]() | N-{[(2R,3R,4R,5R)-3,4-DIHYDROXY- 5-(HYDROXYMETHYL)PYRROLIDIN-2-YL]METHYL}- 4-(DIMETHYLAMINO)BENZAMIDE | A,B | 2OYM | 0.72 | ![]() |
FON![]() | FOLINIC ACID | A,B | 1QD1 | 0.7 | ![]() |
FON![]() | FOLINIC ACID | A,B | 2BLN | 0.7 | ![]() |
FON![]() | FOLINIC ACID | A,B,C,D | 1VRQ | 0.7 | ![]() |
FON![]() | FOLINIC ACID | A,B | 1KL2 | 0.7 | ![]() |
FON![]() | FOLINIC ACID | A,B | 1XZQ | 0.7 | ![]() |
MU1![]() | N~2~-ACETYL-N-[(1S,3S,4S)-4-({[(5S)- 3-(3-ACETYLPHENYL)-2-OXO-1,3-OXAZOLIDIN- 5-YL]CARBONYL}AMINO)-1-BENZYL-3- HYDROXY-5-PHENYLPENTYL]-L-VALINAMIDE | A,B | 2Q54 | 0.75 | ![]() |
575![]() | (4Z)-6-bromo-4-({[4-(pyrrolidin- 1-ylmethyl)phenyl]amino}methylidene)isoquinoline- 1,3(2H,4H)-dione | A,B,C,D | 2ZM3 | 0.71 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A | 1U1J | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 2OGY | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 1XPG | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 1TLS | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B,C | 1ZP4 | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 2E7F | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A | 1TSN | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 2IDK | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 1XR2 | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A | 1B02 | 0.7 | ![]() |
C2F![]() | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | A,B | 1Q8J | 0.7 | ![]() |
AAF![]() | METHYL 4-{[({[(2R,5S)-5-{[(2S)- 2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN- 2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE | B | 2G63 | 0.72 | ![]() |
23I![]() | N-[(1S,2S,4R)-2-HYDROXY-1-ISOBUTYL- 5-({(1S)-1-[(ISOPROPYLAMINO)CARBONYL]- 2-METHYLPROPYL}AMINO)-4-METHYL- 5-OXOPENTYL]-5-[METHYL(METHYLSULFONYL)AMINO]- N'-[(1R)-1-PHENYLETHYL]ISOPHTHALAMIDE | A,B,C,D | 2P4J | 0.71 | ![]() |
RXB![]() | (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo- 1,2,3,4-tetrahydroisoquinolin-5- yl)amino]ethyl acetate | A,B,C,D | 3DEI | 0.75 | ![]() |
XTY![]() | (1R)-1,4-ANHYDRO-2-DEOXY-1-(6-METHYL- 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN- 8-YL)-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL | A,B | 2ICZ | 0.7 | ![]() |
SU2![]() | 3-[4-(1-FORMYLPIPERAZIN-4-YL)-BENZYLIDENYL]- 2-INDOLINONE | A,B | 1AGW | 0.74 | ![]() |
MEF![]() | N-({4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7- hexahydroimidazo[1,5-f]pteridin- 8(9H)-yl]phenyl}carbonyl)-L-glutamic acid | A | 3BGX | 0.7 | ![]() |
NBX![]() | N-{[(4-aminophenyl)carbonyl]carbamoyl}- beta-D-glucopyranosylamine | A | 2QN9 | 0.72 | ![]() |
MU0![]() | (5S)-N-[(1S,2S,4S)-1-BENZYL-2-HYDROXY- 4-{[(2S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN- 1(2H)-YL)BUTANOYL]AMINO}-5-PHENYLPENTYL]- 2-OXO-3-PHENYL-1,3-OXAZOLIDINE- 5-CARBOXAMIDE | A,B | 2Q55 | 0.74 | ![]() |
P34![]() | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO- 5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | A,B | 3GEY | 0.78 | ![]() |
P34![]() | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO- 5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | A | 3CE0 | 0.78 | ![]() |
P34![]() | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO- 5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | A,B | 1XK9 | 0.78 | ![]() |
P34![]() | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO- 5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | A | 2Q6M | 0.78 | ![]() |
P34![]() | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO- 5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | A,B,C,D,E,F | 1ZM9 | 0.78 | ![]() |
I52![]() | N-{4-[(1-HYDROXYCARBAMOYL-2-METHYL- PROPYL)-(2-MORPHOLIN-4-YL-ETHYL)- SULFAMOYL]-4-PENTYL-BENZAMIDE | A | 1HOV | 0.74 | ![]() |
CRI![]() | A,B | 1VKG | 0.7 | ![]() | |
NII![]() | 2,7-bis[3-(dimethylamino)propyl]- 4,9-bis[(3-hydroxypropyl)amino]benzo[lmn][3,8]phenanthroline- 1,3,6,8(2H,7H)-tetrone | A,B | 3CDM | 0.73 | ![]() |
NII![]() | 2,7-bis[3-(dimethylamino)propyl]- 4,9-bis[(3-hydroxypropyl)amino]benzo[lmn][3,8]phenanthroline- 1,3,6,8(2H,7H)-tetrone | A | 3CCO | 0.73 | ![]() |
SY1![]() | 2-({2-[(3R)-3-AMINOPIPERIDIN-1- YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE | A,B,C,D | 2ONC | 0.71 | ![]() |
NNI![]() | O-[2-(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate | A | 2VG7 | 0.71 | ![]() |
MY9![]() | N-{(1S,2S)-1-BENZYL-2-HYDROXY-2- [(4S)-1,2,2-TRIMETHYL-5-OXOIMIDAZOLIDIN- 4-YL]ETHYL}-N'-[(1R)-1-(4-FLUOROPHENYL)ETHYL]- 5-[METHYL(METHYLSULFONYL)AMINO]ISOPHTHALAMIDE | A | 2P8H | 0.73 | ![]() |
PFG![]() | 10-PARPARGYL-5,8-DIDEAZAFOLATE- 4-GLUTAMIC ACID | A,B | 2BBQ | 0.71 | ![]() |
UN7![]() | 3-[3-(3(S)-METHYLCARBAMOYL-7-SULFOAMINO- 3,4,-DIHYDRO-1H-ISOQUINOLIN-2-YL)- 3-OXO-PROPYL]-BENZOIC ACID | A | 2F71 | 0.7 | ![]() |
DQB![]() | 4-[(4-{[(2-AMINO-4-OXO-3,4-DIHYDROQUINAZOLIN- 6-YL)METHYL]AMINO}BENZOYL)AMINO]BUTANOIC ACID | A | 1ZLY | 0.71 | ![]() |
Y14![]() | N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin- 3-yl]amino}-1-(cyclohexylmethyl)- 2-oxoethyl]morpholine-4-carboxamide | A,B | 2R9N | 0.7 | ![]() |
GG1![]() | 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP- 1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN- 3(2H)-YL]METHYL}BENZOIC ACID | A,B,C,D,E,F, G,H | 2OZR | 0.74 | ![]() |
MHF![]() | 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID | X | 2IJG | 0.7 | ![]() |
MHF![]() | 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID | A,B | 2J4D | 0.7 | ![]() |
MHF![]() | 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID | A,B | 1DNP | 0.7 | ![]() |
25D![]() | 2-cyclohexyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen- 2-yl)carbonyl]-D-alanine | A,B | 3DD1 | 0.75 | ![]() |
2T1![]() | 2-[({4-[2-(trifluoromethyl)phenyl]piperidin- 1-yl}carbonyl)amino]benzoic acid | A,B | 3FMZ | 0.73 | ![]() |
SX6![]() | N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin- 1-yl]carbonyl}phenyl)-4-morpholin- 4-yl-4-oxobutanamide | A,B | 3CJ5 | 0.75 | ![]() |
VG7![]() | N-[(1S,2R)-1-benzyl-3-(cyclohexylamino)- 2-hydroxypropyl]-3-(ethylamino)- 5-(2-oxopyrrolidin-1-yl)benzamide | A | 2VJ9 | 0.73 | ![]() |
C47![]() | METHYL (3R)-1-[(5S,6S,8R)-5-AMINO- 9-BUTYLAMINO-6-HYDROXY-3,3,8-TRIMETHYL- 9-OXO-NONANOYL]-3,4-DIHYDRO-2H- QUINOLINE-3-CARBOXYLATE | C,O | 2V16 | 0.72 | ![]() |
GIN![]() | 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3- YL)METHYL]AMINO}-N-[4-PROPYL-3- (TRIFLUOROMETHYL)PHENYL]BENZAMIDE | A,B | 2HZ0 | 0.72 | ![]() |
T42![]() | MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID | H,I | 1AI8 | 0.7 | ![]() |
DRC![]() | 9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]- 4-ACRIDINECARBOXAMIDE | A | 1KCI | 0.72 | ![]() |
VG5![]() | N-[(1S,2R)-1-benzyl-3-{[(1S)-2- (cyclohexylamino)-1-methyl-2-oxoethyl]amino}- 2-hydroxypropyl]-3-(ethylamino)- 5-(2-oxo-2,3-dihydro-1H-pyrrol- 1-yl)benzamide | A | 2VJ6 | 0.74 | ![]() |
VG6![]() | N-[(1S,2R)-1-benzyl-2-hydroxy-3- {[3-(trifluoromethyl)benzyl]amino}propyl]- 3-(ethylamino)-5-(2-oxopyrrolidin- 1-yl)benzamide | A | 2VJ7 | 0.72 | ![]() |
SLD![]() | (3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]- 2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent- 4-en-1-yl]-3-(4-methyl-2,6-dioxo- 1,6-dihydropyrimidin-5(2H)-ylidene)propanamide | 0,2,4,9,A,B, C,H,I,J,K,L, M,N,P,Q,R,S, T,X,Y,Z | 3CXC | 0.71 | ![]() |
ZES![]() | [3-(4-BROMO-2-FLUORO-BENZYL)-7- CHLORO-2,4-DIOXO-3,4-DIHYDRO-2H- QUINAZOLIN-1-YL]-ACETIC ACID | A | 1IEI | 0.7 | ![]() |
989![]() | 2-{[4-(2-ACETYLAMINO-2-PENTYLCARBAMOYL- ETHYL)-NAPHTHALEN-1-YL]-OXALYL- AMINO}-BENZOIC ACID | A | 1NL9 | 0.72 | ![]() |
VG0![]() | N-{(1S,2R)-1-benzyl-2-hydroxy-3- [(1,1,5-trimethylhexyl)amino]propyl}- 3-(ethylamino)-5-(2-oxopyrrolidin- 1-yl)benzamide | A | 2VIE | 0.74 | ![]() |
FRQ![]() | 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN- 1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)- DIONE | A,B | 1UK1 | 0.79 | ![]() |
055![]() | (2S)-{[(3-{[(2-chloro-6-methylphenyl)carbamoyl]amino}naphthalen- 2-yl)carbonyl]amino}(phenyl)ethanoic acid | A,B | 3DDW | 0.71 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A,B,C,D,E,F, G,H | 2ISL | 0.7 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A,B,C,D | 2ZRY | 0.7 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A,B,C,D | 2ZRV | 0.7 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A,B,C,D,E,F, G,H | 2ISK | 0.7 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A,B,C,D | 2ZRZ | 0.7 | ![]() |
FNR![]() | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO- 3,4-DIHYDRO-2H-BENZO[G]PTERIDIN- 1-ID-10(5H)-YL)-5-O-PHOSPHONATO- D-RIBITOL | A | 2FZ5 | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 2NMW | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 3D1Y | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 2NMY | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 3CYX | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 2NNP | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | B | 1C6Z | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 2NNK | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A | 1FB7 | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 2NMZ | 0.7 | ![]() |
ROC![]() | N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)- 3-(tert-butylcarbamoyl)octahydroisoquinolin- 2(1H)-yl]-2-hydroxypropyl}-N~2~- (quinolin-2-ylcarbonyl)-L-aspartamide | A,B | 3D1X | 0.7 | ![]() |
RXC![]() | (1S)-1-(3-chlorophenyl)-2-oxo-2- [(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin- 5-yl)amino]ethyl acetate | A,B,C,D | 3DEJ | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1KCE | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1NCE | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E,F | 1KZJ | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | X | 2FTO | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1TRG | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 2TSC | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1TVU | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1TVV | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1FWM | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1BQ1 | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E | 3DL5 | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1AIQ | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1DDU | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E | 1QZF | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1TDU | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1VZE | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 2G8M | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E | 2OIP | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1CI7 | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1DNA | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1LCA | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1VZD | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1ZPR | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P | 2AAZ | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 2G8O | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A | 1TVW | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D,E | 3DL6 | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B | 1AN5 | 0.71 | ![]() |
CB3![]() | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | A,B,C,D | 2BFA | 0.71 | ![]() |
NHS![]() | 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID | A,B | 1C2T | 0.7 | ![]() |
26B![]() | O-tert-butyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen- 2-yl)carbonyl]-L-threonine | A,B | 3DDS | 0.79 | ![]() |
AN9![]() | 1,5-BIS[3-(DIETHYLAMINO)PROPIONAMIDO]ANTHRACENE- 9,10-DIONE | A,B | 1XCU | 0.75 | ![]() |
XIN![]() | methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin- 1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}- 2-oxo-2,3-dihydro-1H-indole-6-carboxylate | A | 3C7Q | 0.71 | ![]() |